Bausch Health Companies Inc operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Bausch Health Companies Inc with three other
pharmaceutical manufacturers in North America:
Daiichi Sankyo Company Limited
of UNITED STATES
(2019
sales of $8.38 billion
of which 93%
was Prescription drugs),
CSL Limited
of UNITED STATES
($8.54 billion
of which 84%
was CSL Behring), and
Regeneron Pharmaceuticals Incorporated
which is
also
based in UNITED STATES
($7.86 billion
of which 59%
was EYLEA).
Sales Analysis.
During the year ended December of 2019, sales at
Bausch Health Companies Inc were C$11.38 billion (US$8.93 billion).
This
is
an
increase of 4.5%
versus 2018, when the company's sales were C$10.89 billion.
Sales of Salix saw an increase
that was more than double the company's growth rate: sales were up
17.7% in 2019, from
C$2.27 billion to C$2.68 billion.
Not all segments of Bausch Health Companies Inc experienced an increase in sales in 2019:
sales of Ortho Dermatologics fell 8.0% to C$747.60 million.
Bausch Health Companies Inc also experienced decreases in sales in
U.S. Diversified Products Segment (down 3.3% to C$1.69 billion)
.